Sorainen advised Oxipit on the deal, while Walless advised Taiwania. Oxipit raised €3.5 million in investment from the Taiwanese venture capital company Taiwania Capital. Oxipit is a biotech...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here